Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Curasan AG       DE0005494538

CURASAN AG

SummaryNewsRatingsCalendarCompany 
Business Summary
curasan AG is a Germany-based developer, producer and marketer of medical products in the areas of bone and tissue regeneration. The Company focuses on dentistry products and orthopedics. In the dentistry area, the Company focuses on bone regeneration and wound healing, offering CERASORB, Osbone, stypro and foils and membranes, as well as accessories, such as fixation systems. In the orthopedics area, the Company offers CERASORB, stypro and Curavisc for bone regeneration, wound healing and osteoarthritis therapy. The CERASORB product family provides bone replacement material for bone defects. stypro is a sterile and porous sponge from biomaterial that is implantable and resorbable. Osbone is a synthetic open-cell cancellous bone graft material for filling bone defects and for augmentation of the atrophied alveolar ridge.
Managers
NameAgeSinceTitle
Torben Sorensen-2019Chief Executive Officer
Detlef Wilke, Dr.-2009Chairman-Supervisory Board
Fabian Peters, Dr.492012Technical Director
Christine Böhm, Dr.-2018Chief Medical Officer
Isabella de Krassny-2019Member-Supervisory Board
Kurt Berger, Dr.532019Member-Supervisory Board
Gregor Siebert-2015Head-Marketing & Sales
Ingo Middelmenne--Head-Investor Relations
Company contact information
curasan AG
Lindigstrasse 4
Kleinostheim, Bayern (Bavaria) 63801

Phone : +49.6027.40900.0
Fax : +49.6027.40900.29
Web : http://curasan.de